AAAAAA

   
Results: 1-11 |
Results: 11

Authors: HOSKING DJ EUSEBIO RA CHINES AA
Citation: Dj. Hosking et al., PAGETS-DISEASE OF BONE - REDUCTION OF DISEASE-ACTIVITY WITH ORAL RISEDRONATE, Bone, 22(1), 1998, pp. 51-55

Authors: SIRIS ES CHINES AA ALTMAN RD BROWN JP JOHNSTON CC LANG R MCCLUNG MR MALLETTE LE MILLER PD RYAN WG SINGER FR TUCCI JR EUSEBIO RA BEKKER PJ
Citation: Es. Siris et al., RISEDRONATE IN THE TREATMENT OF PAGETS-DISEASE OF BONE - AN OPEN-LABEL, MULTICENTER STUDY, Journal of bone and mineral research, 13(6), 1998, pp. 1032-1038

Authors: ADACHI JD BENSEN WG ANASTASSIADES TP BROWN JP CHINES AA OLSZYNSKI WP HANLY JG STEPHENSON GF
Citation: Jd. Adachi et al., ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS -ONE-YEAR OF FOLLOW-UP ON CALCIUM ONLY, Arthritis and rheumatism, 41(9), 1998, pp. 628-628

Authors: ADACHI JD ROUX C PACK S CHINES AA IOANNIDES G STEPHENSON GF HORLAIT S
Citation: Jd. Adachi et al., PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS WITH ETIDRONATE - POOLED RESULTS FROM 2 CLINICAL-TRIALS, Arthritis and rheumatism, 41(9), 1998, pp. 1624-1624

Authors: ADACHI JD CHINES AA STEPHENSON GF PACK S
Citation: Jd. Adachi et al., INTERMITTENT CYCLICAL THERAPY WITH ETIDRONATE PREVENTS BONE LOSS IN CORTICOSTEROID-TREATED PATIENTS AND REDUCES FRACTURE RATE IN A SUBGROUPOF POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 267-267

Authors: HANLEY D SACCOGIBSON NA ADACHI JD HODSMAN AB BROWN JP PACK S CHINES AA
Citation: D. Hanley et al., ETIDRONATE THERAPY IN PATIENTS ON HIGH-DOSE CORTICOSTEROIDS - DIFFERENCES IN BONE-RESORPTION MARKER RESPONSES, Journal of bone and mineral research, 12, 1997, pp. 626-626

Authors: SACCOGIBSON NA PACK S CHINES AA ADACHI JD
Citation: Na. Saccogibson et al., BONE TURNOVER MARKERS PREDICT CHANGES IN BONE-MINERAL DENSITY IN PATIENTS TREATED WITH CORTICOSTEROIDS, Journal of bone and mineral research, 12, 1997, pp. 635-635

Authors: MILLER PD SACCOGIBSON N CRUSAN C CHINES AA BEKKER PJ
Citation: Pd. Miller et al., TOTAL AND BONE-SPECIFIC ALKALINE-PHOSPHATASE IN MONITORING BISPHOSPHONATE-TREATED PAGETIC PATIENTS, Journal of bone and mineral research, 12, 1997, pp. 671-671

Authors: ADACHI JD BENSEN WG BROWN J HANLEY D HODSMAN A JOSSE R KENDLER DL LENTLE B OLSZYNSKI W STEMARIE LG TENENHOUSE A CHINES AA
Citation: Jd. Adachi et al., INTERMITTENT ETIDRONATE THERAPY TO PREVENT CORTICOSTEROID-INDUCED OSTEOPOROSIS, The New England journal of medicine, 337(6), 1997, pp. 382-387

Authors: ADACHI JD PACK S CHINES AA
Citation: Jd. Adachi et al., INTERMITTENT ETIDRONATE AND CORTICOSTEROID-INDUCED OSTEOPOROSIS - THEAUTHORS REPLY, The New England journal of medicine, 337(26), 1997, pp. 1921-1921

Authors: BENSEN WG ADACHI JD ANASTASSIADES TP BROWN JP CHINES AA OLSZYNSKI WP HANLY JG
Citation: Wg. Bensen et al., INTERMITTENT CYCLICAL THERAPY WITH ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS, Arthritis and rheumatism, 40(9), 1997, pp. 1773-1773
Risultati: 1-11 |